Titan Pharmaceuticals
TTNP
#11004
Rank
ยฃ4.68 M
Marketcap
ยฃ3.52
Share price
-3.76%
Change (1 day)
15.75%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -ยฃ3.38

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ3.35. In 2023 the company made an earnings per share (EPS) of -ยฃ5.66 an increase over its 2022 EPS that were of -ยฃ11.59.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ3.38
2023-ยฃ5.66-51.22%
2022-ยฃ11.59-15.61%
2021-ยฃ13.74-81.37%
2020-ยฃ73.72-77.52%
2019-ยฃ328.01-56.32%
2018-ยฃ750.97-59.51%
2017-ยฃ1,855-371.81%
2016ยฃ682.42-144.35%
2015-ยฃ1,539300%
2014-ยฃ384.64-121.54%
2013ยฃ1,786-151.38%
2012-ยฃ3,476-11.54%
2011-ยฃ3,929188.89%
2010-ยฃ1,360-10%
2009-ยฃ1,511
2007-ยฃ6,195-2.38%
2006-ยฃ6,347-39.13%
2005-ยฃ10,427-16.87%
2004-ยฃ12,542-22.43%
2003-ยฃ16,1694.9%
2002-ยฃ15,41361.9%
2001-ยฃ9,520-13.7%
2000-ยฃ11,03165.01%
1999-ยฃ6,685-35.87%
1998-ยฃ10,425-1824.71%
1997ยฃ604.44-102.4%
1996-ยฃ25,235

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.10-252.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ4.01-219.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-ยฃ3.53 5.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-ยฃ0.15-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ0.18-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ3.32-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA